BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 20369265)

  • 1. Organometallic indolo[3,2-c]quinolines versus indolo[3,2-d]benzazepines: synthesis, structural and spectroscopic characterization, and biological efficacy.
    Filak LK; Mühlgassner G; Jakupec MA; Heffeter P; Berger W; Arion VB; Keppler BK
    J Biol Inorg Chem; 2010 Aug; 15(6):903-18. PubMed ID: 20369265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the piperazine unit and metal-binding site position on the solubility and anti-proliferative activity of ruthenium(II)- and osmium(II)- arene complexes of isomeric indolo[3,2-c]quinoline-piperazine hybrids.
    Filak LK; Kalinowski DS; Bauer TJ; Richardson DR; Arion VB
    Inorg Chem; 2014 Jul; 53(13):6934-43. PubMed ID: 24927493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metal-based paullones as putative CDK inhibitors for antitumor chemotherapy.
    Schmid WF; John RO; Mühlgassner G; Heffeter P; Jakupec MA; Galanski MS; Berger W; Arion VB; Keppler BK
    J Med Chem; 2007 Dec; 50(25):6343-55. PubMed ID: 17997519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological activity of ruthenium and osmium arene complexes with modified paullones in human cancer cells.
    Mühlgassner G; Bartel C; Schmid WF; Jakupec MA; Arion VB; Keppler BK
    J Inorg Biochem; 2012 Nov; 116(5):180-7. PubMed ID: 23037896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjugation of organoruthenium(II) 3-(1H-benzimidazol-2-yl)pyrazolo[3,4-b]pyridines and indolo[3,2-d]benzazepines to recombinant human serum albumin: a strategy to enhance cytotoxicity in cancer cells.
    Stepanenko IN; Casini A; Edafe F; Novak MS; Arion VB; Dyson PJ; Jakupec MA; Keppler BK
    Inorg Chem; 2011 Dec; 50(24):12669-79. PubMed ID: 22111668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Half-sandwich Ru(η
    Huang YC; Haribabu J; Chien CM; Sabapathi G; Chou CK; Karvembu R; Venuvanalingam P; Ching WM; Tsai ML; Hsu SCN
    J Inorg Biochem; 2019 May; 194():74-84. PubMed ID: 30831392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships of highly cytotoxic copper(II) complexes with modified indolo[3,2-c]quinoline ligands.
    Primik MF; Göschl S; Jakupec MA; Roller A; Keppler BK; Arion VB
    Inorg Chem; 2010 Dec; 49(23):11084-95. PubMed ID: 20979395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ruthenium- and Osmium-Arene Complexes of 2-Substituted Indolo[3,2-c]quinolines: Synthesis, Structure, Spectroscopic Properties, and Antiproliferative Activity.
    Filak LK; Mühlgassner G; Bacher F; Roller A; Galanski M; Jakupec MA; Keppler BK; Arion VB
    Organometallics; 2011 Jan; 30(2):273-283. PubMed ID: 21253447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organometallic 3-(1H-benzimidazol-2-yl)-1H-pyrazolo[3,4-b]pyridines as potential anticancer agents.
    Stepanenko IN; Novak MS; Mühlgassner G; Roller A; Hejl M; Arion VB; Jakupec MA; Keppler BK
    Inorg Chem; 2011 Nov; 50(22):11715-28. PubMed ID: 22032295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, characterization and biological evaluation of novel Ru(II)-arene complexes containing intercalating ligands.
    Nikolić S; Rangasamy L; Gligorijević N; Aranđelović S; Radulović S; Gasser G; Grgurić-Šipka S
    J Inorg Biochem; 2016 Jul; 160():156-65. PubMed ID: 26818702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organometallic ruthenium(II) diamine anticancer complexes: arene-nucleobase stacking and stereospecific hydrogen-bonding in guanine adducts.
    Chen H; Parkinson JA; Parsons S; Coxall RA; Gould RO; Sadler PJ
    J Am Chem Soc; 2002 Mar; 124(12):3064-82. PubMed ID: 11902898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derivation of structure-activity relationships from the anticancer properties of ruthenium(II) arene complexes with 2-aryldiazole ligands.
    Martínez-Alonso M; Busto N; Jalón FA; Manzano BR; Leal JM; Rodríguez AM; García B; Espino G
    Inorg Chem; 2014 Oct; 53(20):11274-88. PubMed ID: 25302401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dicopper(II) and dizinc(II) complexes with nonsymmetric dinucleating ligands based on indolo[3,2-c]quinolines: synthesis, structure, cytotoxicity, and intracellular distribution.
    Primik MF; Göschl S; Meier SM; Eberherr N; Jakupec MA; Enyedy É; Novitchi G; Arion VB
    Inorg Chem; 2013 Sep; 52(17):10137-46. PubMed ID: 23952332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel ruthenium(II) arene based intercalator with potent anticancer activity.
    Ruiz J; Vicente C; de Haro C; Bautista D
    Dalton Trans; 2009 Jul; (26):5071-3. PubMed ID: 19562164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenanthroline ligands are biologically more active than their corresponding ruthenium(II) arene complexes.
    Valladolid J; Hortigüela C; Busto N; Espino G; Rodríguez AM; Leal JM; Jalón FA; Manzano BR; Carbayo A; García B
    Dalton Trans; 2014 Feb; 43(6):2629-45. PubMed ID: 24327227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular delivery of pyrenyl-arene ruthenium complexes by a water-soluble arene ruthenium metalla-cage.
    Furrer MA; Schmitt F; Wiederkehr M; Juillerat-Jeanneret L; Therrien B
    Dalton Trans; 2012 Jun; 41(24):7201-11. PubMed ID: 22506276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly cytotoxic copper(II) complexes with modified paullone ligands.
    Primik MF; Mühlgassner G; Jakupec MA; Zava O; Dyson PJ; Arion VB; Keppler BK
    Inorg Chem; 2010 Jan; 49(1):302-11. PubMed ID: 19968251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc(II) complexes with potent cyclin-dependent kinase inhibitors derived from 6-benzylaminopurine: synthesis, characterization, X-ray structures and biological activity.
    Trávnícek Z; Krystof V; Sipl M
    J Inorg Biochem; 2006 Feb; 100(2):214-25. PubMed ID: 16386795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions.
    Peacock AF; Habtemariam A; Fernández R; Walland V; Fabbiani FP; Parsons S; Aird RE; Jodrell DI; Sadler PJ
    J Am Chem Soc; 2006 Feb; 128(5):1739-48. PubMed ID: 16448150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bipyrimidine ruthenium(II) arene complexes: structure, reactivity and cytotoxicity.
    Betanzos-Lara S; Novakova O; Deeth RJ; Pizarro AM; Clarkson GJ; Liskova B; Brabec V; Sadler PJ; Habtemariam A
    J Biol Inorg Chem; 2012 Oct; 17(7):1033-51. PubMed ID: 22791215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.